ArticleNeoplasia (New York, N.Y.)2018

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.

Raelene Endersby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.